Regeneron Pharmaceuticals (REGN) Earnings Date, Estimates & Call Transcripts $603.58 -2.03 (-0.34%) Closing price 05/5/2025 04:00 PM EasternExtended Trading$602.65 -0.93 (-0.15%) As of 04:57 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Regeneron Pharmaceuticals Earnings Summary Latest Q1 Earnings DateApr. 29EstimatedConsensus EPS (Apr. 29) $8.83 Actual EPS (Apr. 29) $8.22 Missed By -$0.61 Actual Revenue (Apr. 29) $3.03BRegeneron Pharmaceuticals posted Q1 2025 earnings on April 29, 2025, reporting an EPS of $8.22, which missed the consensus estimate of $8.83 by $0.61. Quarterly revenue fell 3.7% year-over-year to $3.03 billion, below the consensus estimate of $3.40 billion. With a trailing EPS of $39.28 and a P/E Ratio of 15.77, Regeneron Pharmaceuticals' earnings are expected to grow 5.85% next year, from $35.92 to $38.02 per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q) Slide DeckSlide DeckFull Screen Slide DeckPowered by Get Regeneron Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Regeneron Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataREGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.REGN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Regeneron Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251$7.07$7.07$7.07Q2 20251$8.22$8.22$8.22Q3 20251$9.62$9.62$9.62Q4 20251$9.56$9.56$9.56 Regeneron Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails4/29/2025Q1 2025$8.83$8.22 -$0.61$7.27$3.40B$3.03B2/4/2025Q4 2024$11.21$12.07+$0.86$8.06$3.76B$3.79B8/1/2024Q2 2024$8.93$11.56+$2.63$7.79$3.38B$3.55B5/2/2024Q1 2024$8.46$7.97 -$0.49$9.67$3.19B$3.15B2/2/2024Q4 2023$10.73$11.86+$1.13$10.17$3.29B$3.43B11/2/2023Q3 2023$9.39$10.17+$0.78$11.45$3.23B$3.36B8/3/2023Q2 2023$8.48$10.24+$1.76$9.08$3.02B$3.16B Regeneron Pharmaceuticals Earnings - Frequently Asked Questions When did Regeneron Pharmaceuticals announce their last quarterly earnings? Regeneron Pharmaceuticals (NASDAQ:REGN) last announced its quarterly earning data on Tuesday, April 29, 2025. Learn more on REGN's earnings history. Did Regeneron Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Regeneron Pharmaceuticals (NASDAQ:REGN) missed the analysts' consensus estimate of $8.83 by $0.61 with a reported earnings per share (EPS) of $8.22. Learn more on analysts' earnings estimate vs. REGN's actual earnings. How can I listen to Regeneron Pharmaceuticals's earnings conference call? The conference call for Regeneron Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Regeneron Pharmaceuticals's conference call transcript? The conference call transcript for Regeneron Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Regeneron Pharmaceuticals generate each year? Regeneron Pharmaceuticals (NASDAQ:REGN) has a recorded annual revenue of $14.09 billion. How much profit does Regeneron Pharmaceuticals generate each year? Regeneron Pharmaceuticals (NASDAQ:REGN) has a recorded net income of $4.41 billion. REGN has generated $39.28 earnings per share over the last four quarters. What is Regeneron Pharmaceuticals's price-to-earnings ratio? Regeneron Pharmaceuticals (NASDAQ:REGN) has a trailing price-to-earnings ratio of 15.77 and a forward price-to-earnings ratio of 16.80. The price/earnings-to-growth ratio is 2.34. What is Regeneron Pharmaceuticals's EPS forecast for next year? Regeneron Pharmaceuticals's earnings are expected to grow from $35.92 per share to $38.02 per share in the next year, which is a 5.85% increase. More Earnings Resources from MarketBeat Related Companies AMGN Earnings GILD Earnings VRTX Earnings ALNY Earnings BIIB Earnings UTHR Earnings BMRN Earnings INCY Earnings EXEL Earnings NBIX Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback Plan This page (NASDAQ:REGN) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy REGN Stock Free REGN Stock Alerts